Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.920
-0.140 (-6.80%)
At close: Feb 21, 2025, 4:00 PM
1.980
+0.060 (3.13%)
After-hours: Feb 21, 2025, 7:58 PM EST
Editas Medicine Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$8.08
Upside
+320.83%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Evercore ISI Group | Evercore ISI Group | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +160.42% | Dec 16, 2024 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Dec 16, 2024 |
RBC Capital | RBC Capital | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +108.33% | Dec 13, 2024 |
Barclays | Barclays | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +56.25% | Dec 13, 2024 |
Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
Baird | Baird | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +316.67% | Dec 13, 2024 |
Stifel | Stifel | Strong Buy → Hold Downgrades $11 → $3 | Strong Buy → Hold | Downgrades | $11 → $3 | +56.25% | Dec 13, 2024 |
Wells Fargo | Wells Fargo | Buy → Hold Downgrades $7 → $4 | Buy → Hold | Downgrades | $7 → $4 | +108.33% | Dec 11, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +525.00% | Nov 5, 2024 |
RBC Capital | RBC Capital | Hold Maintains $8 → $5 | Hold | Maintains | $8 → $5 | +160.42% | Nov 5, 2024 |
Stifel | Stifel | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +472.92% | Nov 5, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +316.67% | Nov 5, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +264.58% | Nov 5, 2024 |
Barclays | Barclays | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +160.42% | Nov 5, 2024 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $3 | Hold | Maintains | $7 → $3 | +56.25% | Oct 23, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $27 → $9 | Buy | Maintains | $27 → $9 | +368.75% | Oct 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.